Meeting
2021 ASCO Annual Meeting
MRI and targeted biopsies compared to transperineal mapping biopsies for targeted ablation in recurrent prostate cancer after radiotherapy: Primary outcomes of the FORECAST trial.
Authors
Taimur T. Shah
Imperial College London, London, United Kingdom
Taimur T. Shah , Abi Kanthabalan , Menelaos Pavlou , Sola Adeleke , Francesco Giganti , Chris Brew-Graves , Athar Haroon , Harbir Sidhu , Alex Freeman , Ashok Nikapota , Tim Dudderidge , Richard G Hindley , Manit Arya , Heather Ann Payne , Anita Mitra , Gail Horan , Caroline Moore , Mark Emberton , Shonit Punwani , Hashim Uddin Ahmed
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer– Advanced/Castrate-Resistant
Clinical Trial Registration Number
NCT01883128
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5009)
DOI
10.1200/JCO.2021.39.15_suppl.5009
Abstract #
5009
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Oncological outcomes of 356 patients undergoing salvage focal ablative HIFU or cryotherapy following radiation failure.
First Author: Deepika Reddy
Poster
2024 ASCO Genitourinary Cancers Symposium
Impact of exposure to clinical trials and standard-of-care therapy in metastatic or recurrent prostate cancer: An update.
First Author: Grace G Kim
Poster
2024 ASCO Genitourinary Cancers Symposium
Systemic and tumor-directed therapy for oligometastatic prostate cancer (SOLAR): A phase II trial for veterans with de novo oligometastatic prostate cancer.
First Author: Nicholas George Nickols
Poster
2024 ASCO Genitourinary Cancers Symposium
Days spent with healthcare contact by patients with metastatic castrate-resistant prostate cancer in the last year of life.
First Author: Daniel Sentana Lledo